期刊文献+

let-7/miR-98家族对Fas基因的调节作用 被引量:4

The regulation of Fas expression by let-7/miR-98 family
原文传递
导出
摘要 Fas在自身免疫病及肿瘤中发挥重要的作用。微小RNA是一种起负调控作用的分子。本研究旨在探索微小RNA对Fas基因的调节作用。生物信息学分析可能调节Fas基因表达的微小RNA,并通过聚合酶链反应(RT-PCR)和流式细胞术检测其对Fas基因表达的影响。利用定点突变和双荧光报告基因系统来验证微小RNA对Fas基因的直接调节作用。最后通过流式细胞术检测微小RNA对Fas介导的细胞凋亡的影响。结果,生物信息学分析发现let-7/miR-98家族可以调节Fas基因的表达。过表达miR-98可以降低Fas基因蛋白和mRNA水平的表达,反之,抑制miR-98可以增加Fas基因的表达。双荧光报告基因系统及定点突变实验显示:let-7/miR-98家族可直接调节Fas基因3'UTR。细胞凋亡检测显示:过表达miR-98可抑制Fas介导的细胞凋亡,抑制miR-98可以增加Fas介导的细胞凋亡。这说明let-7/miR-98家族可以直接调节Fas基因的表达并影响Fas介导的细胞凋亡,并可能成为干预Fas参与的相关疾病的一种新药物。 Fas plays an important role in autoimmune and neoplastic disease,and microRNA acts as a negative regulator that modulates target gene expression.This study was to investigate the microRNA which can regulate the expression and function of Fas.The microRNA which can regulate Fas expression was analyzed by bioinformatics.Real-time PCR and flow cytometry were used to test Fas mRNA and protein expression levels,respectively.Site-directed gene mutagenesis and reporter gene assay were performed to identify microRNA exerting their regulation on Fas 3'UTR directly.Apoptosis was assessed by annexin-V staining using flow cytometry.The experimental results showed that let-7/miR-98 family was predicted to regulate Fas by bioinformatics.Over-expression of miR-98 significantly reduced the expression of Fas at both protein and messenger RNA levels, whereas reduction of miR-98 expression conversely increased Fas at both levels.Furthermore,let-7/miR-98 could target Fas 3'UTR directly.More importantly,over-expression of miR-98 decreased cellular' sensitivity to Fas-induced apoptosis, and vise versa.These findings indicate that let-7/miR-98 down-regulate Fas expression and decrease cellular sensitivity to Fasinduced apoptosis.And let-7/miR-98 may provide a potential novel strategy for therapeutic intervention of Fas-related diseases.
出处 《现代免疫学》 CAS CSCD 北大核心 2010年第3期177-182,共6页 Current Immunology
基金 国家高新技术发展计划(863)项目(2007AA02Z123) 中国科学院上海生命科学研究院知识创新工程青年人才领域前沿项目(2007KIP305) 国家自然基金项目(30700734 30301026 30971632) 上海市自然科学基金项目(07ZR14130) 上海市科委重点项目(08JC1414700)
关键词 微小RNA let-7/miR-98家族 FAS基因 let-7/miR-98 family Fas gene
  • 相关文献

参考文献35

  • 1崔慧娟,唐元家,罗晓兵,邓筠,郭彦芝,黄新芳,陈顺乐,沈南.系统性红斑狼疮患者中miR-146a表达缺陷与I型干扰素通路过度活化相关[J].现代免疫学,2008,28(4):279-284. 被引量:13
  • 2Kertesz M, Iovino N, Unnerstall U,et al. The role of site accessibility in microRNA target recognition[J]. Nat Genet, 2007,39:1278 -1284.
  • 3Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis[J].Nature, 1992,356: 314-317.
  • 4Cianga C, Cianga P, Cozma L,et al. The significance of Fas/ FasL molecular system in breast cancer[J]. Rev Med Chir Soc Med Nat Iasi, 2004,108:440-444.
  • 5Chopin V, Toillon RA, Jouy N, et al. Sodium butyrate induces P53 independent, Fas mediated apoptosis in MCF-7 human breast cancer cells[J]. Br J Pharmacol, 2002, 135: 79-86.
  • 6Yoshimoto Y, Kawada M, Ikeda D, et al. Involvement of doxorubicin induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo[J]. Int Immunopharmacol, 2005,5 :281-288.
  • 7Nozawa K, Kayagaki N, Tokano Y, et al. Soluble Fas (APO1, CD95) and soluble Fas ligand in rheumatic diseases [J]. Arthritis Rheum, 1997,40:1126-1129.
  • 8Ates A, Kinikli G, Turgay M,et al. The levels of serum soluble Fas in patients with rheumatoid arthritis and systemic sclerosis[J]. Clin Rheumatol, 2004,23:421 -425.
  • 9Sahin M, Aydintug O, Tunc SE,et al. Serum soluble Fas levels in patients with autoimmune rheumatic diseases[J].Clin Biochem, 2007,40:6-10.
  • 10Cheng J, Zhou T, Liu C, etal. Protection from Fas mediated apoptosis by a soluble form of the Fas molecule[J]. Science, 1994,263:1759-1762.

二级参考文献18

  • 1华晶,沈南,陈顺乐.Ly-6E与系统性红斑狼疮[J].现代免疫学,2004,24(5):435-436. 被引量:1
  • 2[10]Yu P,Wellmann U,Kunder S,et al.Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE[J].Int Immunol,2006,18(8):1211-1219.
  • 3[11]Papadimitraki ED,Choulaki C,Koutala E,et al.Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus:implications for the induction and maintenance of the autoimmune process[J].Arthritis Rheum,2006,54(11):3601-3611.
  • 4[12]Han GM,Chen SL,Shen N,et al.Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray[J].Genes Immun,2003,4(3):175-176.
  • 5[15]Feng X,Wu H,Grossman JM,et al.Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus[J].Arthritis Rheum,2006,54(9):2951-2962.
  • 6[16]Calin GA,Croce CM.Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance[J].Semin Oncol,2006,33(2):167-173.
  • 7[17]Porkka KP,Pfeiffer MJ,Waltering KK,et al.MicroRNA expression profiling in prostate cancer[J].Cancer Res,2007,67(13):6130-6135.
  • 8[18]Dai Y,Huang YS,Tang M,et al.Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients[J].Lupus,2007,16(12):939-946.
  • 9[1]Ambros V.The functions of animal microRNAs[J].Nature,2004,431(7006):350-355.
  • 10[2]Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-297.

共引文献12

同被引文献37

  • 1肖月星,倪青,钱秋海.糖肝康胶囊治疗糖尿病性肝损伤30例临床研究[J].中国中医药信息杂志,2006,13(7):17-19. 被引量:12
  • 2肖月星,倪青,钱秋海,林兰.糖肝康胶囊对糖尿病大鼠糖脂代谢及肝损伤影响的研究[J].医学研究杂志,2007,36(2):108-110. 被引量:12
  • 3Iorio MV,Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer[J]. Cancer Res ,2007,67 ( 18 ) : 8699 -8707.
  • 4Nam E J, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma [ J ]. Clin Cancer Res, 2008,14 ( 9 ) : 2690 - 2695.
  • 5Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform[J]. Gynecol Oncol,2009,112 ( 1 ) : 55 -59.
  • 6Yu J, Wang F, Yang GH, et al. Human microRNA clusters : Genomie organization and expression profile in leukemia cell lines [ J ]. Biochem Biophys Res Commun,2006,349( 1 ) :59-68.
  • 7Sukata T, Sumida K, Kushida M, et al. Circulating microRNAs,possible indicators of progress of rat hepatocarcinogenesis from early stages[J]. Toxicol Lett,2010,200( 1 ) :46-52.
  • 8Yan LX, Huang XF, Shao Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis [ J ]. RNA, 2008,14 ( 11 ) :2348 -2360.
  • 9Hebert C, Norris K, Scheper MA, et al. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma[ J]. Mol Cancer,2007,6 ( 1 ) :5-16.
  • 10Du L,Schageman JJ,Subauste MC, et al. miR-93 ,miR-98 ,and miR.197 regulate expression of tumor suppressor gene FUS1 [ J ]. Mol Cancer Res,2009,7 (8) : 1234-1243.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部